I am owing 500k this week... NPHC news coming this week on sales contracts.
The publication from Grass Roots Research and Distribution, Inc., which was commissioned by Nutra Pharma, focuses on the company's current drug development initiatives, including the company's leading drug candidates for the treatment of Multiple Sclerosis (MS), HIV, Adrenomyeloneuropathy (AMN), and Rheumatoid Arthritis (RA) as well as the company's recent launch of Cobroxin and Nyloxin, treatments for chronic pain. A PDF of the research report can be accessed at: http://www.grassrootsrd.com/grassrootsrd/Reports/Nutra_Pharma_Corp_05_12_2010.pdf About Grass Roots Research and Distribution, Inc. The Grass Roots Research and Cohen Research brand names are the worldwide Gold Standard for micro cap/small cap research. Grass Roots has raised the art of fundamental securities research by forecasting the three statements and valuing all of its companies in three cases over a 5 year time period. Grass Roots distributes in-depth stock market research reports that highlight the company's market opportunity, technology, management, competition and other key differentiators that may affect their short and long term valuation.